Testing a Blood Pressure Medicine for High Red Blood Cell Count
Treatments studied
Part of Blood & lymphatic clinical trials.
This study tests whether lisinopril, a common blood pressure medication, can help lower red blood cell counts in people who have elevated hemoglobin levels. Researchers want to see if this drug could offer a simpler treatment option for this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Hemoglobin level above 16.5 g/dL (men) or 16.0 g/dL (women)—meaning you have more red blood cells than normal
- Body mass index (BMI) between 18 and 40—a measure based on your height and weight
- Not currently taking ACE inhibitors or potassium-sparing diuretics (blood pressure or water pills)
- Not a current smoker, and if you quit smoking, it must have been at least 12 months ago
- No history of severe allergic reactions (anaphylaxis) or facial swelling (angioedema)
- Blood pressure between 90/60 and 160/100 mmHg—not too low or too high
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether CPAP therapy (a machine that helps keep your airway open while you sleep) can lower high red blood cell counts in people who have both sleep apnea and polycythemia. It may help reduce the need for other treatments.
This study follows people with high red blood cell counts (erythrocytosis) who are seen at a blood specialty clinic. The goal is to track their health over time to learn more about this condition and how it affects patients.
This trial studies whether regular blood removal (phlebotomy) can change your heart rate in people with polycythaemia who already need these blood draws regularly. If you qualify, you may be asked to use a smartphone during the study so researchers can track your heart rate changes over time.
This study looks at people who have higher-than-normal hemoglobin and platelet counts. It aims to better understand the biology behind these blood changes and how they may be related to disease.
This trial studies proteins and red blood cell production in people with polycythemia (high red blood cell count) to understand its causes. It may help improve care for patients with this condition.
This study tests a treatment called remote ischemic conditioning (using a blood pressure cuff to briefly stop blood flow in your arm, which is thought to protect the body) to see if it can help people with high-altitude polycythemia, a condition where your body makes too many red blood cells because of the thin air at high altitudes.
Hear when a new Polycythemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.